307 related articles for article (PubMed ID: 11998442)
1. [Pyrrolo(2,3-c)quinolines and pyrrolo(3,4-d)quinolines--synthesis and investigation of lipoxygenase inhibition].
Görlitzer K; Fabian J; Frohberg P; Drutkowski G
Pharmazie; 2002 Apr; 57(4):243-9. PubMed ID: 11998442
[TBL] [Abstract][Full Text] [Related]
2. [Pyridazino(3,4-c)quinolines and pyridazino(4,5-c)quinolines--synthesis and investigation of lipoxygenase inhibition].
Görlitzer K; Fabian J; Jones PG; Frohberg P; Drutkowski G
Pharmazie; 2002 Jun; 57(6):362-71. PubMed ID: 12116871
[TBL] [Abstract][Full Text] [Related]
3. [Furo(2,3-c)quinolines and furo(3,4-c)quinolones--synthesis and investigation of lipoxygenase inhibition].
Görlitzer K; Fabian J; Jones PG; Frohberg P; Drutkowski G
Pharmazie; 2002 Mar; 57(3):159-68. PubMed ID: 11933842
[No Abstract] [Full Text] [Related]
4. Synthesis and structure-activity relationship of 4-substituted 2-(2-acetyloxyethyl)-8-(morpholine-4-sulfonyl)pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors.
Kravchenko DV; Kuzovkova YA; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Balakin KV; Ivachtchenko AV
J Med Chem; 2005 Jun; 48(11):3680-3. PubMed ID: 15916416
[TBL] [Abstract][Full Text] [Related]
5. [Pyrano[3,4-c]quinolines from 1-desaza--oxa-nifedipine].
Görlitzer K; Trittmacher J; Jones PG; Frohberg P; Drutkowski G
Pharmazie; 2003 Aug; 58(8):539-42. PubMed ID: 12967028
[TBL] [Abstract][Full Text] [Related]
6. Total synthesis of (-)-martinellic acid via radical addition-cyclization-elimination reaction.
Shirai A; Miyata O; Tohnai N; Miyata M; Procter DJ; Sucunza D; Naito T
J Org Chem; 2008 Jun; 73(12):4464-75. PubMed ID: 18473441
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation.
Ergün BC; Nuñez MT; Labeaga L; Ledo F; Darlington J; Bain G; Cakir B; Banoglu E
Arzneimittelforschung; 2010; 60(8):497-505. PubMed ID: 20863006
[TBL] [Abstract][Full Text] [Related]
8. [Thieno[2,3-c]quinolines - synthesis and biological investigation].
Görlitzer K; Gabriel B; Frohberg P; Wobst I; Drutkowski G; Wiesner J; Jomaa H
Pharmazie; 2004 Jun; 59(6):439-42. PubMed ID: 15248457
[TBL] [Abstract][Full Text] [Related]
9. [Benzo[c][2,7]naphthyridines from 2,6-dinor-nifedipine and its dimethyl 2,5-dicarboxylate isomer].
Görlitzer K; Bode M; Frohberg P; Drutkowski G
Pharmazie; 2004 Jan; 59(1):15-20. PubMed ID: 14964415
[TBL] [Abstract][Full Text] [Related]
10. Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530.
Dubé D; Blouin M; Brideau C; Chan CC; Desmarais S; Ethier D; Falgueyret JP; Friesen RW; Girard M; Girard Y; Guay J; Riendeau D; Tagari P; Young RN
Bioorg Med Chem Lett; 1998 May; 8(10):1255-60. PubMed ID: 9871745
[TBL] [Abstract][Full Text] [Related]
11. A highly efficient and selective Au(I)-catalyzed tandem synthesis of diversely substituted pyrrolo[1,2-a]quinolines in aqueous media.
Liu XY; Che CM
Angew Chem Int Ed Engl; 2008; 47(20):3805-10. PubMed ID: 18399561
[No Abstract] [Full Text] [Related]
12. BAY X1005, a new selective inhibitor of leukotriene synthesis: pharmacology and pharmacokinetics.
Müller-Peddinghaus R; Fruchtmann R; Ahr HJ; Beckermann B; Bühner K; Fugmann B; Junge B; Matzke M; Kohlsdorfer C; Raddatz S
J Lipid Mediat; 1993; 6(1-3):245-8. PubMed ID: 8395246
[TBL] [Abstract][Full Text] [Related]
13. Generation of 4-polyfluoroaryl pyrrolo[1,2-a]quinolines via C-H bond activation.
Ye S; Liu J; Wu J
Chem Commun (Camb); 2012 May; 48(41):5028-30. PubMed ID: 22497010
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiproliferative activity of some new DNA-targeted alkylating pyrroloquinolines.
Ferlin MG; Dalla Via L; Gia OM
Bioorg Med Chem; 2004 Feb; 12(4):771-7. PubMed ID: 14759737
[TBL] [Abstract][Full Text] [Related]
15. CGS 22745: a selective orally active inhibitor of 5-lipoxygenase.
Kimble E; Kowalski T; White D; Raychauduri A; Pastor G; Chertock H; Lee W; Neale R; Hamdan A; Wasley J
Agents Actions; 1991 Sep; 34(1-2):125-8. PubMed ID: 1665286
[TBL] [Abstract][Full Text] [Related]
16. An expedient approach to pyrrolo[3,2-c]quinolines via regioselective formation of the pyrrole nucleus over indoles.
Karkhelikar MV; Jha RR; Sridhar B; Likhar PR; Verma AK
Chem Commun (Camb); 2014 Aug; 50(62):8526-8. PubMed ID: 24950020
[TBL] [Abstract][Full Text] [Related]
17. 1H-pyrrolo[2,3-f]quinoline and isoquinoline derivatives: synthesis and antiproliferative activity.
Ferlin MG; Chiarelotto G; Basadonna O; Gia O; Mobilio S; Baccichetti F; Carlassare F
Farmaco; 1989 Dec; 44(12):1141-55. PubMed ID: 2634405
[TBL] [Abstract][Full Text] [Related]
18. [Lipoamino acids and lipopeptides as potential 5- and 12-lipoxygenase inhibitors].
Presenz P
Pharmazie; 1997 Feb; 52(2):164-5. PubMed ID: 9122277
[No Abstract] [Full Text] [Related]
19. 5-Lipoxygenase inhibition by N-hydroxycarbamates in dual-function compounds.
Lewis TA; Bayless L; DiPesa AJ; Eckman JB; Gillard M; Libertine L; Scannell RT; Wypij DM; Young MA
Bioorg Med Chem Lett; 2005 Feb; 15(4):1083-5. PubMed ID: 15686917
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and caspase-3 inhibitory activity of 8-sulfonyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines.
Kravchenko DV; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Ivachtchenko AV
Farmaco; 2005 Oct; 60(10):804-9. PubMed ID: 16182295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
